Radioimmunotherapy Market Report

Global and Region Radioimmunotherapy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：230
  • REPORT CODE：GMM897433
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Radioimmunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Radioimmunotherapymarket, defines the market attractiveness level of Radioimmunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Radioimmunotherapy industry, describes the types of Radioimmunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Radioimmunotherapy market and the development prospects and opportunities of Radioimmunotherapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Radioimmunotherapy market in Chapter 13.

    By Player:

    • Bayer Healthcare Pharmaceuticals

    • BioSynthema

    • Clarity Pharmaceuticals

    • Curasight

    • Endocyte

    • Immunomedics

    • Molecular Insight Pharmaceuticals

    • Nordic Nanovector

    • PDL Biopharma

    • Philogen

    • RadioMedix

    • Stella Pharma

    • Telix Pharmaceuticals

    By Type:

    • Non Hodgkin Lymphoma (NHL)

    • Follicular Lymphoma

    • Solid Tumors

    • Breast Cancer

    • Ovarian Cancer

    • Osteosarcoma

    • Neuroblastoma

    • Prostate Cancer

    By End-User:

    • Tumor Antigens

    • Radionuclides

    • Antibodies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Radioimmunotherapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Radioimmunotherapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Radioimmunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Radioimmunotherapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Radioimmunotherapy Market Analysis and Outlook to 2022

    • 7.1 Global Radioimmunotherapy Consumption (2017-2022)

    • 7.2 United States Radioimmunotherapy Consumption (2017-2022)

    • 7.3 Europe Radioimmunotherapy Consumption (2017-2022)

    • 7.4 China Radioimmunotherapy Consumption (2017-2022)

    • 7.5 Japan Radioimmunotherapy Consumption (2017-2022)

    • 7.6 India Radioimmunotherapy Consumption (2017-2022)

    • 7.7 South Korea Radioimmunotherapy Consumption (2017-2022)

    8 Region and Country-wise Radioimmunotherapy Market Analysis and Outlook to 2028

    • 8.1 Global Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.2 United States Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.3 Europe Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.4 China Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.5 Japan Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.6 India Radioimmunotherapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Radioimmunotherapy Consumption Forecast (2022-2028)

    9 Global Radioimmunotherapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Radioimmunotherapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Non Hodgkin Lymphoma (NHL) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Follicular Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Solid Tumors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Osteosarcoma Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Neuroblastoma Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • 9.2 Global Radioimmunotherapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Antigens Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Radionuclides Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Antibodies Consumption and Growth Rate (2017-2022)

    10 Global Radioimmunotherapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Radioimmunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Non Hodgkin Lymphoma (NHL) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Follicular Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Osteosarcoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Radioimmunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Tumor Antigens Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Radionuclides Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Radioimmunotherapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Radioimmunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Radioimmunotherapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Radioimmunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Radioimmunotherapy Market Competitive Analysis

    • 14.1 Bayer Healthcare Pharmaceuticals

      • 14.1.1 Bayer Healthcare Pharmaceuticals Company Details

      • 14.1.2 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product and Service

    • 14.2 BioSynthema

      • 14.2.1 BioSynthema Company Details

      • 14.2.2 BioSynthema Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BioSynthema Radioimmunotherapy Product and Service

    • 14.3 Clarity Pharmaceuticals

      • 14.3.1 Clarity Pharmaceuticals Company Details

      • 14.3.2 Clarity Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Clarity Pharmaceuticals Radioimmunotherapy Product and Service

    • 14.4 Curasight

      • 14.4.1 Curasight Company Details

      • 14.4.2 Curasight Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Curasight Radioimmunotherapy Product and Service

    • 14.5 Endocyte

      • 14.5.1 Endocyte Company Details

      • 14.5.2 Endocyte Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Endocyte Radioimmunotherapy Product and Service

    • 14.6 Immunomedics

      • 14.6.1 Immunomedics Company Details

      • 14.6.2 Immunomedics Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Immunomedics Radioimmunotherapy Product and Service

    • 14.7 Molecular Insight Pharmaceuticals

      • 14.7.1 Molecular Insight Pharmaceuticals Company Details

      • 14.7.2 Molecular Insight Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Product and Service

    • 14.8 Nordic Nanovector

      • 14.8.1 Nordic Nanovector Company Details

      • 14.8.2 Nordic Nanovector Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nordic Nanovector Radioimmunotherapy Product and Service

    • 14.9 PDL Biopharma

      • 14.9.1 PDL Biopharma Company Details

      • 14.9.2 PDL Biopharma Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 PDL Biopharma Radioimmunotherapy Product and Service

    • 14.10 Philogen

      • 14.10.1 Philogen Company Details

      • 14.10.2 Philogen Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Philogen Radioimmunotherapy Product and Service

    • 14.11 RadioMedix

      • 14.11.1 RadioMedix Company Details

      • 14.11.2 RadioMedix Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 RadioMedix Radioimmunotherapy Product and Service

    • 14.12 Stella Pharma

      • 14.12.1 Stella Pharma Company Details

      • 14.12.2 Stella Pharma Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Stella Pharma Radioimmunotherapy Product and Service

    • 14.13 Telix Pharmaceuticals

      • 14.13.1 Telix Pharmaceuticals Company Details

      • 14.13.2 Telix Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Telix Pharmaceuticals Radioimmunotherapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Radioimmunotherapy

    • Figure Radioimmunotherapy Picture

    • Table Global Radioimmunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Radioimmunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Radioimmunotherapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Radioimmunotherapy Consumption by Country (2017-2022)

    • Figure United States Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Table Europe Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Figure China Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Figure India Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Radioimmunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radioimmunotherapy Consumption Forecast by Country (2022-2028)

    • Figure United States Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Radioimmunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non Hodgkin Lymphoma (NHL) Consumption and Growth Rate (2017-2022)

    • Figure Global Follicular Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Solid Tumors Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Osteosarcoma Consumption and Growth Rate (2017-2022)

    • Figure Global Neuroblastoma Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Antigens Consumption and Growth Rate (2017-2022)

    • Figure Global Radionuclides Consumption and Growth Rate (2017-2022)

    • Figure Global Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Non Hodgkin Lymphoma (NHL) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Follicular Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteosarcoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Antigens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radionuclides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Radioimmunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Radioimmunotherapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer Healthcare Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product and Service

    • Table BioSynthema (Foundation Year, Company Profile and etc.)

    • Table BioSynthema Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioSynthema Radioimmunotherapy Product and Service

    • Table Clarity Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Clarity Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clarity Pharmaceuticals Radioimmunotherapy Product and Service

    • Table Curasight (Foundation Year, Company Profile and etc.)

    • Table Curasight Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curasight Radioimmunotherapy Product and Service

    • Table Endocyte (Foundation Year, Company Profile and etc.)

    • Table Endocyte Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endocyte Radioimmunotherapy Product and Service

    • Table Immunomedics (Foundation Year, Company Profile and etc.)

    • Table Immunomedics Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics Radioimmunotherapy Product and Service

    • Table Molecular Insight Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Molecular Insight Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Molecular Insight Pharmaceuticals Radioimmunotherapy Product and Service

    • Table Nordic Nanovector (Foundation Year, Company Profile and etc.)

    • Table Nordic Nanovector Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordic Nanovector Radioimmunotherapy Product and Service

    • Table PDL Biopharma (Foundation Year, Company Profile and etc.)

    • Table PDL Biopharma Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table PDL Biopharma Radioimmunotherapy Product and Service

    • Table Philogen (Foundation Year, Company Profile and etc.)

    • Table Philogen Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Philogen Radioimmunotherapy Product and Service

    • Table RadioMedix (Foundation Year, Company Profile and etc.)

    • Table RadioMedix Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table RadioMedix Radioimmunotherapy Product and Service

    • Table Stella Pharma (Foundation Year, Company Profile and etc.)

    • Table Stella Pharma Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stella Pharma Radioimmunotherapy Product and Service

    • Table Telix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Telix Pharmaceuticals Radioimmunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Telix Pharmaceuticals Radioimmunotherapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US